Showing 1 posts of 1 posts found.
Chinese firm Lumis Global Pharmaceuticals became the latest to face the FDA’s ire as it was hit by a warning …
Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
ESTEVE CDMO adds $17.5m to Illinois expansion
AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials
Brenntag and dsm-firmenich expand biopharma vitamin partnership